U.S. flag

An official website of the United States government

NC_000023.10:g.(?_135067662)_(136652229_?)del AND Hyper-IgM syndrome type 1

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jun 27, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001956451.7

Allele description [Variation Report for NC_000023.10:g.(?_135067662)_(136652229_?)del]

NC_000023.10:g.(?_135067662)_(136652229_?)del

Genes:
Variant type:
Deletion
Cytogenetic location:
Xq26.3
Genomic location:
ChrX: 135067662 - 136652229 (on Assembly GRCh37)
Preferred name:
NC_000023.10:g.(?_135067662)_(136652229_?)del
HGVS:
NC_000023.10:g.(?_135067662)_(136652229_?)del

Condition(s)

Name:
Hyper-IgM syndrome type 1
Synonyms:
Immunodeficiency with hyper IgM type 1; Hyper IgM immunodeficiency, X-linked; Hyper-IgM Immunodeficiency Syndrome, Type 1; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0010626; MedGen: C0398689; OMIM: 308230

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002243681Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Jun 27, 2022)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

The hyper IgM syndrome--an evolving story.

Etzioni A, Ochs HD.

Pediatr Res. 2004 Oct;56(4):519-25. Epub 2004 Aug 19. Review.

PubMed [citation]
PMID:
15319456

Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome.

Lee WI, Torgerson TR, Schumacher MJ, Yel L, Zhu Q, Ochs HD.

Blood. 2005 Mar 1;105(5):1881-90. Epub 2004 Sep 9.

PubMed [citation]
PMID:
15358621
See all PubMed Citations (4)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002243681.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

A gross deletion of the genomic region encompassing the full coding sequence of the CD40LG gene has been identified. Loss-of-function variants in CD40LG are known to be pathogenic (PMID: 15319456). The boundaries of this event are unknown as they extend beyond the assayed region for this gene and therefore may encompass additional genes. A similar copy number variant has been observed in individual(s) with hyper IgM syndrome (PMID: 15358621, 16019685). For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024